Devonian Health Group Inc.
GSD.V
TSX
| 01/31/2025 | 10/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 38.57% | -32.84% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 38.57% | -32.84% | |||
| Cost of Revenue | 44.07% | -27.00% | |||
| Gross Profit | 27.04% | -42.49% | |||
| SG&A Expenses | -16.10% | 7.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -2.59% | 6.42% | |||
| Total Operating Expenses | 23.30% | -15.40% | |||
| Operating Income | 140.98% | -147.17% | |||
| Income Before Tax | 133.15% | -156.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 63.92% | -156.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 63.92% | -156.28% | |||
| EBIT | 140.98% | -147.17% | |||
| EBITDA | 166.51% | -131.52% | |||
| EPS Basic | 63.33% | -156.60% | |||
| Normalized Basic EPS | 131.58% | -157.58% | |||
| EPS Diluted | 63.33% | -156.60% | |||
| Normalized Diluted EPS | 131.58% | -157.58% | |||
| Average Basic Shares Outstanding | 0.00% | -0.01% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||